Skip to main content

Advertisement

SpringerLink
Log in

Prevention and Management of Contrast-Induced Acute Kidney Injury

  • Coronary Artery Disease (PH Stone, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Contrast-induced acute kidney injury (AKI) is an important complication associated with coronary angiography, percutaneous coronary intervention, and computed tomography studies. The increasing utilization of contrast agents for imaging makes the importance of this complication even greater. Patients can be risk stratified for the risk of contrast-induced AKI by several clinical factors including hypotension, renal function, age, advanced heart failure, anemia, and diabetes mellitus. Contrast volume is also an important and modifiable risk factor for AKI. For the prevention of contrast-induced AKI, multiple approaches have been tried. The most effective prevention strategy is hydration. Normal saline has been the standard, but other options such as sodium bicarbonate may be a reasonable alternative. Further studies will be required to clarify the best preventive strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–6.

    Article  PubMed  Google Scholar 

  2. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.

    Article  PubMed  Google Scholar 

  3. James MT, Ghali WA, Knudtson ML, Ravani P, Tonelli M, Faris P, Pannu N, Manns BJ, Klarenbach SW, Hemmelgarn BR: Alberta provincial project for outcome assessment in coronary heart disease (approach) investigators. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 123(4):409–416.

    Article  PubMed  Google Scholar 

  4. McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–75.

    Article  PubMed  CAS  Google Scholar 

  5. Budano C, Levis M, D’Amico M, Usmiani T, Fava A, Sbarra P, Burdese M, Segoloni GP, Colombo A, Marra S: Impact of contrast-induced acute kidney injury definition on clinical outcomes. Am Heart J (2011);161(5):963–971.

    Article  PubMed  Google Scholar 

  6. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Chronic kidney disease epidemiology collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–54.

    PubMed  CAS  Google Scholar 

  7. Lakhal K, Ehrmann S, Chaari A, Laissy JP, Régnier B, Wolff M, Pajot O: Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: Incidence and outcome. J Crit Care (2011) Jul 5. [Epub ahead of print]. This study determined the incidence of AKI following contrast-enhanced computed tomography in patients in the intesive care unit using the Acute Kidney Injury Network defintions. They found the incidence to be 14%, and AKI was associated with a higher mortaliy (odds ratio 3.85).

  8. Guitterez NV, Diaz A, Timmis GC, O’Neill WW, Stevens MA, Sandberg KR, McCullough PA. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Intervent Cardiol. 2002;15(5):349–54.

    Article  PubMed  Google Scholar 

  9. Sendeski MM: Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharm Physio (2011);38(4):292–299.

    Article  CAS  Google Scholar 

  10. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004;44:1391–9.

    Google Scholar 

  11. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O’Neill WW. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515–9.

    Article  PubMed  Google Scholar 

  12. Tepel M, van der Giet M, Schwartzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180–4.

    Article  PubMed  CAS  Google Scholar 

  13. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of n-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65:1366–74.

    Article  PubMed  CAS  Google Scholar 

  14. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148(4):284–94.

    PubMed  Google Scholar 

  15. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK. Prospective randomized study of n-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv. 2002;57(3):279–83.

    Article  PubMed  Google Scholar 

  16. Azmus AD, Gottschall C, Manica A, Manica J, Duro K, Frey M, Bulcão L, Lima C. Effectiveness of acetylcysteine in prevention of contrast nephropathy. J Invasive Cardiol. 2005;17(2):80–4.

    PubMed  Google Scholar 

  17. Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ. A rapid protocol for the prevention of contrast-induced renal dysfunction: The rappid study. J Am Coll Cardiol. 2003;41:2114–8.

    Article  PubMed  Google Scholar 

  18. Sar F, Saler T, Ecebay A, Saglam ZA, Ozturk S, Kazancioglu R: The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy. J Nephrol (2010) 23(4):478–482.

    PubMed  Google Scholar 

  19. Thiele H, Hildebrand L, Schirdewahn C, Eitel I, Adams V, Fuernau G, Erbs S, Linke A, Diederich KW, Nowak M, Desch S et al.: Impact of high-dose n-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate. PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) trial. J Am Coll Cardiol (2010);55(20):2201–2209.

    Article  PubMed  CAS  Google Scholar 

  20. Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH: Effect of N-acetylcysteine on cystatin c-based renal function after elective coronary angiography (ENABLE study): A prospective, randomized trial. Int J Cardiol (2010) 138(3):239–245.

    Article  PubMed  Google Scholar 

  21. Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, Dutka P, Marzo K, Maesaka JK, Fishbane S. A randomized controlled trial of n-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int. 2002;62(6):2202–7.

    Article  PubMed  CAS  Google Scholar 

  22. Weisbord SD, Palevsky PM: Strategies for the prevention of contrast-induced acute kidney injury. Curr Opin Nephrol Hypertens (2010) 19(6):539–549.

    Article  PubMed  Google Scholar 

  23. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354(26):2773–82.

    Article  PubMed  CAS  Google Scholar 

  24. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton 3rd CA, Rittase RA, Norton HJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA. 2004;291:2328.

    Article  PubMed  CAS  Google Scholar 

  25. Briguori C, Airoldi F, D’Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, et al. Renal insufficiency following contrast media administration trial (remedial): A randomized comparison of 3 preventive strategies. Circulation. 2007;115(10):1211–7.

    PubMed  CAS  Google Scholar 

  26. From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol. 2008;3(1):10–8.

    Article  PubMed  CAS  Google Scholar 

  27. Vasheghani-Farahani A, Sadigh G, Kassaian SE, Khatami SM, Fotouhi A, Razavi SA, Mansournia MA, Yamini-Sharif A, Amirzadegan A, Salarifar M, Sadeghian S et al: Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: A randomized controlled trial. Am J Kidney Dis (2009) 54(4):610–618.

    Article  PubMed  CAS  Google Scholar 

  28. Tamura A, Goto Y, Miyamoto K, Naono S, Kawano Y, Kotoku M, Watanabe T, Kadota J: Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. Am J Cardiol (2009) 104(7):921–925.

    Article  PubMed  CAS  Google Scholar 

  29. Hoste EA, De Waele JJ, Gevaert SA, Uchino S, Kellum JA: Sodium bicarbonate for prevention of contrast-induced acute kidney injury: A systematic review and meta-analysis. Nephrol Dial Transplant (2010) 25(3):747–758.

    Article  PubMed  CAS  Google Scholar 

  30. Meier P, Ko DT, Tamura A, Tamhane U, Gurm HS: Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: A meta-analysis. BMC Med (2009) 7:23.

    Article  PubMed  Google Scholar 

  31. Ho KM, Morgan DJ. Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: A meta-analysis. Anaesth Intensive Care. 2008;36(5):646–53.

    PubMed  CAS  Google Scholar 

  32. Brown JR, Block CA, Malenka DJ, O’Connor GT, Schoolwerth AC, Thompson CA: Sodium bicarbonate plus n-acetylcysteine prophylaxis: A meta-analysis. JACC Cardiovasc Interv (2009) 2(11):1116–1124.

    Article  PubMed  Google Scholar 

  33. Erley CM. Does hydration prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant. 1999;14(5):1064–6.

    Article  PubMed  CAS  Google Scholar 

  34. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. AJR Am J Roentgenol. 1981;136(5):859–61.

    PubMed  CAS  Google Scholar 

  35. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329–36.

    Article  PubMed  CAS  Google Scholar 

  36. Eisenhart E, Benson S, Lacombe P, Himmelfarb J, Zimmerman R, Schimelman B, Parker MG: Safety of low volume iodinated contrast administration for arteriovenous fistula intervention in chronic kidney disease stage 4 or 5 utilizing a bicarbonate prophylaxis strategy. Semin Dial (2010) 23(6):638–642.

    Article  PubMed  Google Scholar 

  37. Kane GC, Doyle BJ, Lerman A, Barsness GW, Best PJ, Rihal CS. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol. 2008;51(1):89–90.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Patricia J. M. Best MD & David R. Holmes Jr. MD

Authors
  1. Patricia J. M. Best MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David R. Holmes Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patricia J. M. Best MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Best, P.J.M., Holmes, D.R. Prevention and Management of Contrast-Induced Acute Kidney Injury. Curr Treat Options Cardio Med 14, 1–7 (2012). https://doi.org/10.1007/s11936-011-0162-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-011-0162-5

Keywords

Search

Navigation